IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics: A predictor for survival

Timothy R McGuire, Nicole T. Reardon, Kimberly Bogard, Troy J Plumb, Chris J. Bultsma, Steve W. Nissen, Patrick D. Fuller, Keith M. Olsen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: The present study evaluated interleukin-6 (IL6) as a predictor of mortality in patients and sepsis with acute kidney injury (AKI) receiving sustained low-efficiency dialysis (SLED) and antibiotic therapy. Patients and Methods: Seven patients with sepsis receiving antibiotics and SLED for AKI were studied. Blood was obtained at baseline prior to SLED and antibiotics, during SLED, and then after stopping SLED. IL6 concentrations were measured using an enzyme-linked immunosorbent assay (ELISA). Results: Mean plasma IL6 concentrations ranged between 700 and 900 pg/ml for the first 8 h after starting SLED but was significantly lower after discontinuation of SLED (200-250 pg/ml) (p=0.0044). Three out of seven patients survived to be discharged from the hospital and all three had significantly lower concentrations of IL6 during the first 8 h compared to those who died in the hospital (p<0.0001). Conclusion: The combination of SLED and antibiotic therapy was unable to lower the initial high plasma IL6 concentrations, and high initial IL6 concentrations predicted in-hospital mortality.

Original languageEnglish (US)
Pages (from-to)1131-1134
Number of pages4
JournalIn Vivo
Volume28
Issue number6
StatePublished - Nov 1 2014

Fingerprint

Dialysis
Interleukin-6
Sepsis
Anti-Bacterial Agents
Plasmas
Survival
Acute Kidney Injury
Immunosorbents
Hospital Mortality
Assays
Blood
Enzyme-Linked Immunosorbent Assay
Mortality
Enzymes
Therapeutics

Keywords

  • IL6
  • SLED
  • Sepsis
  • Survival

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

McGuire, T. R., Reardon, N. T., Bogard, K., Plumb, T. J., Bultsma, C. J., Nissen, S. W., ... Olsen, K. M. (2014). IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics: A predictor for survival. In Vivo, 28(6), 1131-1134.

IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics : A predictor for survival. / McGuire, Timothy R; Reardon, Nicole T.; Bogard, Kimberly; Plumb, Troy J; Bultsma, Chris J.; Nissen, Steve W.; Fuller, Patrick D.; Olsen, Keith M.

In: In Vivo, Vol. 28, No. 6, 01.11.2014, p. 1131-1134.

Research output: Contribution to journalArticle

McGuire, TR, Reardon, NT, Bogard, K, Plumb, TJ, Bultsma, CJ, Nissen, SW, Fuller, PD & Olsen, KM 2014, 'IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics: A predictor for survival', In Vivo, vol. 28, no. 6, pp. 1131-1134.
McGuire, Timothy R ; Reardon, Nicole T. ; Bogard, Kimberly ; Plumb, Troy J ; Bultsma, Chris J. ; Nissen, Steve W. ; Fuller, Patrick D. ; Olsen, Keith M. / IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics : A predictor for survival. In: In Vivo. 2014 ; Vol. 28, No. 6. pp. 1131-1134.
@article{2814c72fd7c3492abe1586f79431838e,
title = "IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics: A predictor for survival",
abstract = "Background: The present study evaluated interleukin-6 (IL6) as a predictor of mortality in patients and sepsis with acute kidney injury (AKI) receiving sustained low-efficiency dialysis (SLED) and antibiotic therapy. Patients and Methods: Seven patients with sepsis receiving antibiotics and SLED for AKI were studied. Blood was obtained at baseline prior to SLED and antibiotics, during SLED, and then after stopping SLED. IL6 concentrations were measured using an enzyme-linked immunosorbent assay (ELISA). Results: Mean plasma IL6 concentrations ranged between 700 and 900 pg/ml for the first 8 h after starting SLED but was significantly lower after discontinuation of SLED (200-250 pg/ml) (p=0.0044). Three out of seven patients survived to be discharged from the hospital and all three had significantly lower concentrations of IL6 during the first 8 h compared to those who died in the hospital (p<0.0001). Conclusion: The combination of SLED and antibiotic therapy was unable to lower the initial high plasma IL6 concentrations, and high initial IL6 concentrations predicted in-hospital mortality.",
keywords = "IL6, SLED, Sepsis, Survival",
author = "McGuire, {Timothy R} and Reardon, {Nicole T.} and Kimberly Bogard and Plumb, {Troy J} and Bultsma, {Chris J.} and Nissen, {Steve W.} and Fuller, {Patrick D.} and Olsen, {Keith M.}",
year = "2014",
month = "11",
day = "1",
language = "English (US)",
volume = "28",
pages = "1131--1134",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics

T2 - A predictor for survival

AU - McGuire, Timothy R

AU - Reardon, Nicole T.

AU - Bogard, Kimberly

AU - Plumb, Troy J

AU - Bultsma, Chris J.

AU - Nissen, Steve W.

AU - Fuller, Patrick D.

AU - Olsen, Keith M.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Background: The present study evaluated interleukin-6 (IL6) as a predictor of mortality in patients and sepsis with acute kidney injury (AKI) receiving sustained low-efficiency dialysis (SLED) and antibiotic therapy. Patients and Methods: Seven patients with sepsis receiving antibiotics and SLED for AKI were studied. Blood was obtained at baseline prior to SLED and antibiotics, during SLED, and then after stopping SLED. IL6 concentrations were measured using an enzyme-linked immunosorbent assay (ELISA). Results: Mean plasma IL6 concentrations ranged between 700 and 900 pg/ml for the first 8 h after starting SLED but was significantly lower after discontinuation of SLED (200-250 pg/ml) (p=0.0044). Three out of seven patients survived to be discharged from the hospital and all three had significantly lower concentrations of IL6 during the first 8 h compared to those who died in the hospital (p<0.0001). Conclusion: The combination of SLED and antibiotic therapy was unable to lower the initial high plasma IL6 concentrations, and high initial IL6 concentrations predicted in-hospital mortality.

AB - Background: The present study evaluated interleukin-6 (IL6) as a predictor of mortality in patients and sepsis with acute kidney injury (AKI) receiving sustained low-efficiency dialysis (SLED) and antibiotic therapy. Patients and Methods: Seven patients with sepsis receiving antibiotics and SLED for AKI were studied. Blood was obtained at baseline prior to SLED and antibiotics, during SLED, and then after stopping SLED. IL6 concentrations were measured using an enzyme-linked immunosorbent assay (ELISA). Results: Mean plasma IL6 concentrations ranged between 700 and 900 pg/ml for the first 8 h after starting SLED but was significantly lower after discontinuation of SLED (200-250 pg/ml) (p=0.0044). Three out of seven patients survived to be discharged from the hospital and all three had significantly lower concentrations of IL6 during the first 8 h compared to those who died in the hospital (p<0.0001). Conclusion: The combination of SLED and antibiotic therapy was unable to lower the initial high plasma IL6 concentrations, and high initial IL6 concentrations predicted in-hospital mortality.

KW - IL6

KW - SLED

KW - Sepsis

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84918548909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918548909&partnerID=8YFLogxK

M3 - Article

C2 - 25398811

AN - SCOPUS:84918548909

VL - 28

SP - 1131

EP - 1134

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 6

ER -